Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Hippo signaling pathway, Cell biology, Cancer research, Biology, Ubiquitin, and KRAS.
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy
Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation
Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation
Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis